NEW YORK, July 17 – Sangamo BioSciences has agreed to prepare genetically engineered cells and deliver them to Pharmacia for screening small molecule drugs, Sangamo said Tuesday.

Sangamo, of Richmond, Calif., will use its zinc finger DNA-binding protein transcription factor (ZFP TF) technology to overexpress certain proteins in cell lines. Pharmacia, based in Peapack, NJ, will take the cells and use them to screen its library of small molecule compounds to determine how well they bind with the proteins.